Cel "OUR MISSION is to save 1.5 million lives globally each year by delivering the right diagnosis. SOCIETAL PROBLEM: To err is human. But in medicine, errors cost lives. ""The delivery of health care has proceeded for decades with a blind spot: Diagnostic errors - inaccurate or delayed diagnoses - persist throughout all settings of care and continue to harm an unacceptable number of patients."" - Institute of Medicine. Studies have shown a devastating rate of misdiagnoses ranging from 10 to 40%. Diagnostic errors cause 10% of patient deaths. +20k diseases cognitively overwhelm doctors. Only 3% of doctors are satisfied with existing research tools. Misdiagnoses account for €446 billion in wasted costs in the EU and $750 billion in the US. Solving misdiagnosis could free up 30% of total healthcare budgets globally. Patients with rare diseases suffer most. 22 of 30 million patients with rare diseases in the EU don’t have their diagnosis yet, and 8 million had to wait 10 years in average. This leaves doctors and patients with a high unmet need. SOLUTION: Symptoma.com is a free search engine for diseases. Users enter symptoms and receive a list of matching causes – sorted by probability. COMPETITIVE ADVANTAGE: Symptoma’s diagnostic accuracy has outdone all competitors’ raising the bar for this field as first and only viable solution. We have demonstrated (1) technological success, (2) high demand, and (3) willingness to pay for our solution operating at a profit with pilot customers. OUR GOAL is to improve diagnostic quality while reducing cost and time spent. We will attain this goal by pushing Symptoma to the next level by (deep) learning from search behaviour, asking questions (cognitive intelligence), and overcoming language barriers. This project is the first step towards a new paradigm of diagnostic decision making. We will fully capitalize on the business opportunity counteracting misdiagnoses for companies dealing with rare diseases." Dziedzina nauki nauki przyrodniczeinformatykabazy danychmedycyna i nauki o zdrowiumedycyna klinicznamedycyna wewnętrzna Program(-y) H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme H2020-EU.3. - PRIORITY 'Societal challenges H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies Temat(-y) EIC-SMEInst-2018-2020 - SME instrument Zaproszenie do składania wniosków H2020-EIC-SMEInst-2018-2020 Zobacz inne projekty w ramach tego zaproszenia Szczegółowe działanie H2020-SMEInst-2018-2020-2 System finansowania SME-2 - SME instrument phase 2 Koordynator SYMPTOMA GMBH Wkład UE netto € 1 597 400,00 Adres Neuhofen 5 4864 Attersee Austria Zobacz na mapie MŚP Organizacja określiła się jako MŚP (firma z sektora małych i średnich przedsiębiorstw) w czasie podpisania umowy o grant. Tak Region Westösterreich Oberösterreich Traunviertel Linki Kontakt z organizacją Opens in new window Uczestnictwo w unijnych programach w zakresie badań i innowacji Opens in new window sieć współpracy HORIZON Opens in new window Środki z innych źródeł € 684 600,00
